Core Viewpoint - Concord Medical Services Holdings Limited will hold its 2025 annual general meeting of shareholders on December 29, 2025, with no proposals for shareholder approval, focusing instead on discussions between shareholders and management [1]. Group 1: Company Overview - Concord Medical is a healthcare provider specializing in a full cycle of premium oncology services, including cancer diagnosis, treatment, education, and prevention [2]. - The company aims to enhance the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics, as well as partnerships with other hospitals across China [2]. Group 2: Meeting Details - The annual general meeting will take place at Room 26A1-26A5, East Tower, Hanwei Building, Beijing, China, at 10:00 a.m. (Beijing Time) [1]. - The shareholder record date is set for December 19, 2025, and the notice of the meeting is available on the company's investor relations website [1].

Core Viewpoint - Concord Medical Services Holdings Limited has filed its annual report for the fiscal year ended December 31, 2024, with the U.S. Securities and Exchange Commission, highlighting its commitment to transparency and regulatory compliance [1]. Company Overview - Concord Medical is a healthcare provider specializing in a full cycle of premium oncology services, including cancer diagnosis, treatment, education, and prevention [2]. - The company focuses on multidisciplinary cancer care and operates cancer hospitals equipped with advanced technology, such as a state-of-the-art proton therapy system [2]. - Concord Medical aims to enhance the quality and accessibility of cancer care through its network of self-owned and partnered hospitals and clinics across China [2].